ABOUT US

 

AUSTRIANOVA is a cutting edge Biotech company based in Singapore embracing leading world quality standards for the production of cell-based products.

Our Quality System is German made and data is stored in duplicate sites in Switzerland. Our equipment is custom made by leading German and US manufacturers. Our team is international and we converse and do business in English.

Our expertise and technologies are backed up by more than 50 international peer reviewed publications, as well as by contracts from leading pharmaceutical and biotech companies.

We are experts in Cell Biology, GMP-grade Cell Products and Encapsulation of Living Cells

The Management

Dr. Brian Salmons

Dr. Brian Salmons

CEO & President

Dr. Brian Salmons is the CEO & President and one of the founders of the company.
He has had 25 years experience in biotech, which commenced with him being appointed the Scientific Director of Bavarian Nordic (BN). He co-founded Austrianova Biotechnology GmbH in 2001 as well as Austrianova in 2007, where he also became the CEO.
Past experiences include being directly responsible for the initial Phase I/II clinical trials of an encapsulated cell product in pancreatic cancer in humans and mammary (breast) cancer in dogs as well as being part of the team that took Bavarian Nordic to its IPO in 1998. He has also been an advisor/consultant for a number of Biotech companies.
Before moving to the commercial world in 1994, he spent 10 in years in academia.

Prof. Walter H. Günzburg

Prof. Walter H. Günzburg

Chairman & CTO

Prof. Walter H. Günzburg, Ph.D. is the Chairman and one of the founders of the company.
He is also Professor of Virology at the University of Veterinary Medicine, Vienna, Austria and formerly an Adjunct Professor at the National University of Singapore. He was a founder, board member and former Chairman of Virusure GmbH, a virus testing company located in Vienna, Austria that has recently been acquired by Asahi-Kasei and has also been an advisor to Paktis (Germany) and Tocagen (USA).
He has also served as a member of German Federal Medical Association Ethics Committee for Gene Therapy (Kommission Somatische Gentherapie der Bundesärztekammer) since 1997 as well as the European Academy for the Study of Consequences of Scientific and Technological Advances (since 1998).
Prof. Günzburg has 40 years experience in virology, and 25 years experience in cell therapy and bioencapsulation. He has published numerous peer reviewed scientific publications.

Dr. John Dangerfield

Dr. John Dangerfield

Chief Operating Officer

Dr John Dangerfield was appointed Chief Operating Officer of SG Austria in 2010, having previously been Head of Laboratory (2007-2010). John began his career in 1996 undertaking toxicology studies for the service provider Hammilton-Garrod in Bedfordshire, England. Following this he worked in Quality Control of injectable products for GE Healthcare (formerly Amersham Pharmacia Biotech) in Gloucester. He moved to Austria in 1997 and completed his PhD in molecular virology in 2001 from the University of Vienna. As a post-doctoral fellow at the University of Veterinary Medicine in Vienna from 2001-2007 he worked with bionanotech approaches for cancer therapy.
He was a Council Member for the bio-industry alliance organisation BioSingapore from 2011-2014 and a committee member for the Singapore Stem Cell Consortium’s yearly international symposium in 2015, John has co-authored 20 peer-reviewed journal articles, 3 book chapters, and edited two books.

Mr. Rahul Pawa

Mr. Rahul Pawa

Chief Production Officer

Rahul is a third-generation Thai of Indian origin. He finished secondary school in Bangkok and moved to Australia to complete his Bachelor degree in Biomedicine with Honours from the University of Melbourne. Rahul spent his honours year researching at the prestigious Peter MacCallum Cancer Centre under the supervision of Dr. Mark Shackleton. He then moved back to Bangkok as the first employee of the newly founded Austrianova Thailand. Rahul has been with Austrianova Thailand for the past 7 years and is currently the Chief Production Officer of the company. In 2018, Rahul was awarded the TIYAA STEM award for his work in overseeing the manufacturing of the first cell therapy in Thailand; a treatment for pancreatic cancer that will be going into phase 2 clinical trials in the US in 2020. Through his work at Austrianova, Rahul is well very connected with the biotech and pharma landscape of Thailand.

 

Ms. Louise Bussieres

Ms. Louise Bussieres

Chief Financial Officer

Louise is a certified Chartered Accountant with 30 years experience in accounting and finance.  She is also Principal of Bussieres Consulting Pte Ltd. Prior to 2010, Ms. Bussieres was the Vice-President, Finance of LAB Research Inc. and Chief Financial Officer of LAB International Inc., two publicly traded Canadian pharmaceutical research organizations which she brought to IPO. From 1995 to 1999, she was Associate Director of the Experimental Biology Centre, the pre-clinical facility of the Institute of National Scientific Research of Quebec. She has been CFO at Exocyte Therapeutics, Singapore and is currently also President and CFO at JSS Medical Research, Canada.

Frequently Asked Questions

About US

AUSTRIANOVA is a cutting edge Biotech company based in Singapore embracing leading world quality standards for the production of cell-based products.

Our Quality System is German made and data is stored in duplicate sites in Switzerland. Our equipment is custom made by leading German and US manufacturers. Our team is international and we converse and do business in English.

Our expertise and technologies are backed up by more than 50 international peer reviewed publications, as well as by contracts from leading pharmaceutical and biotech companies.

We are experts in Cell Biology, GMP-grade Cell Products and Encapsulation of Living Cells

What we offer
Why we can help you
Get more information now